Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
Gregory Y.H. Lip(Medical University of Białystok), Maria Bartlett, Changsheng Ma(Second Hospital of Shandong University), Subhash Banerjee(Baylor University Medical Center), Paul J.A.M. Brouwers(Medisch Spectrum Twente), Antonio Baldi, Menno V. Huisman(Leiden University Medical Center), Agnieszka Kotalczyk(Medical University of Silesia), Sabrina Marler(Boehringer Ingelheim (United States)), Christine Teutsch(Boehringer Ingelheim (Germany)), Erik Badings(Deventer Ziekenhuis), Donald Brautigam, Claude Brunschwig, John Bullinga, Drew Bradman, Ermentina Bagni, Adriana Antonella Bruni(Azienda Ospedaliera San Gerardo), Pedro Adragão(Hospital de Santa Cruz), Seth Baker, Sergio Agosti, Dzifa Wosornu Abban, Aurélie Buhl, Srinivas Addala, Luciano Marcelo Backes, Sérgio Dubner, Richard Bala, Gonzalo Barón‐Esquivias(San Raffaele University of Rome), Marica Bracic Kalan, Kenneth J. Rothman(Boston University), Piergiuseppe Agostoni(University of Milan), Nicolas Breton, Walter Ageno(University of Padua), Venkatesh Kumar Gurusamy(Boehringer Ingelheim (Germany)), Jordi Bruguera Cortada, Francisco Aguilar(Jefferson Einstein Philadelphia Hospital), Alan J. Bank(United Heart and Vascular Clinic), Jonathan L. Halperin(Icahn School of Medicine at Mount Sinai), Hervé Buathier, Rajesh Aggarwal(Southend University Hospital NHS Foundation Trust), Emad F. Aziz(Mount Sinai Hospital), Hans‐Christoph Diener(Vivantes Klinikum), Luis Aguinaga(Centro Científico Tecnológico - Tucumán), Shigenobu Bando(Tottori Prefectural Kousei Hospital), Nasser Abdul, Kevin F. Browne(Watson Clinic), Atilio Marcelo Abud, Julio Aguilar Linares, Craig Barr(Russells Hall Hospital), Fran Adams
Cited by 35
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k